4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000009
Options or other derivatives
- SVP, Chief Legal Officer acquired 337,730 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BUCHEN DAVID A SVP, Chief Legal Officer | 2019-01-03 | Grant or award · Stock Option | +227,273 | 227,273 | D: show line 1 in the form | |||||
| BUCHEN DAVID A SVP, Chief Legal Officer | 2019-01-03 | Grant or award · Restricted Stock Units | +110,457 | 110,457 | D: show line 2 in the form |
Loading xslF345X03/wf-form4_154690177391907.xml…